[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337990-105":59,"doc-detail-337990-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","integrative-genomic-analysis-reveals-cancer-associated-mutations-in-patients-with-ophthalmic-tumors","Integrative Genomic Analysis Reveals Cancer-Associated Mutations in Patients With Ophthalmic Tumors","","Objective: Determine genomic events associated with poor outcomes in ophthalmic tumor patients beyond the known role of the retinoblastoma gene. Methods: Retrospective analysis of 48 patients across six ophthalmic tumor types using combined exome and transcriptome sequencing to find high-frequency mutated genes and susceptibility genes. Results: Four clearly causative genes (TP53, PTCH1, SMO, BAP1), hotspot susceptibility genes (RUNX1, APC, IDH2, BRCA2), and 5868 differentially expressed genes; pathway enrichment implicated PI3K-Akt signaling and transcriptional misregulation in cancer. Conclusions: TP53 and PI3K-Akt are strongly linked to tumorigenesis, and additional genes require functional validation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrative-genomic-analysis-reveals-cancer-associated-mutations-in-patients-with-ophthalmic-tumors/337990/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrative-genomic-analysis-reveals-cancer-associated-mutations-in-patients-with-ophthalmic-tumors/337990.png","ImageObject",300,407,{"name":92,"@type":93},"Liam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the objective of the study regarding ophthalmic tumors?","Question",{"text":112,"@type":113},"To clarify genomic events linked to poor outcomes in ophthalmic tumor patients, beyond the role of the retinoblastoma gene (RB1).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were genes and mutations identified in the methods section?",{"text":117,"@type":113},"The study used combined exome sequencing and transcriptome sequencing to detect somatic point/small indel variants, copy-number variations, susceptibility genes, and driver genes in tumor and control samples.",{"name":119,"@type":110,"acceptedAnswer":120},"Which signaling pathway and key genes were concluded to be involved in ophthalmic tumorigenesis?",{"text":121,"@type":113},"TP53 was highlighted as clearly involved, especially in basal cell carcinoma, and pathway enrichment suggested PI3K-Akt signaling as essential; RUNX1, SMO, TOP2A, and ZWINT were also implicated for further validation.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337990,1790193499,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Integrative genomic analysis reveals cancer-associated mutations in patients with ophthalmic tumors  \nFengjiao Zhu 1,* , Pengpeng Wang 1,*, Zhiyuan Zhang 1, Chunlei Yao2, Yijie Wang2, Juan Ye2 and Jian Wu 1  \nJournal of International Medical Research 2024, Vol. 52(7) 1–13! The Author(s) 2024 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/03000605241258171](DOI: 10.1177/03000605241258171)[ ](DOI: 10.1177/03000605241258171)[journals.sagepub.com/home/imr](journals.sagepub.com/home/imr)  \nAbstract  \nObjective: Apart from the role of the retinoblastoma gene, the genomic events associated with poor outcomes in patients with ophthalmic tumors are poorly understood.  \nMethods: We retrospectively analyzed 48 patients with six types of ophthalmic tumors. We searched for high-frequency mutated genes and susceptibility genes in these patients using combined exome and transcriptome analysis.  \nResults: We identified four clearly causative genes (TP53, PTCH1, SMO, BAP1). Susceptibility gene analysis identified hotspot genes, including RUNX1, APC, IDH2, and BRCA2, and high-frequency gene analysis identified several genes, including TP53, TTN, and MUC16 . Transcriptome analysis identified 5868 differentially expressed genes, of which TOP2A and ZWINTwere upregulated in all samples, while CFD, ELANE, HBA1, and HBB were downregulated. Kyoto Encyclopedia of Genes and Genomes enrichment analysis indicated that the phosphoinositide 3-kinase (PI3K)-Akt and Transcriptional misregulation in cancer signaling pathways may be involved in ophthalmic tumorigenesis.  \nConclusions: TP53 is clearly involved in ophthalmic tumorigenesis, especially in basal cell carcinoma, and the PI3K-Akt signaling pathway may be an essential pathway involved in ophthalmic tumorigenesis. RUNX1, SMO, TOP2A, and ZWINT are also highly likely to be involved in ophthalmic tumorigenesis, but further functional experiments are needed to verify the mechanisms of these genes in regulating tumorigenesis.  \n1 MyGenostics Inc., Beijing, China  \n2Department of Ophthalmology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China  \n*These authors contributed equally to this work. Corresponding author:  \nJian Wu, Block A, Juhong Building, Area B, Airport Industrial Park, Shunyi District, Beijing 101318, China.  \nEmail: [jw2231@mygeno.cn](jw2231@mygeno.cn)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative  \nCommons Attribution-NonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages ([https://us.sagepub.com/en-us/nam/open-access-at-sage](https://us.sagepub.com/en-us/nam/open-access-at-sage)).  \nKeywords  \nExon sequencing, RNA-Seq, ophthalmic tumor, susceptibility gene, TP53, PI3K-Akt signaling pathway  \nDate received: 12 September 2023; accepted: 4 May 2024  \nIntroduction  \nTumors pose a considerable threat to human health and are among the most common and serious diseases. Tumors can occur in almost any part of the body, including most of the tissues in the eye, except the lens.1 Research on ophthalmic tumors has greatly contributed to the understanding of tumor pathogenesis.2,3 The retinoblastoma gene (RB1), as the first identified oncogene and one of the most extensively studied tumor suppressor genes, is well known in this context4,5; however, compared with retinoblastoma, other ophthalmic tumors have received lessintensive study,6 mainly because of their complex origin and classification.7 The current study aimed to explore the specific mutational profiles of ophthalmic tumors to provide a theoretical foundation for subsequent targeted cl","cbCaitgBMQNJUZq4","https://ap.wps.com/l/cbCaitgBMQNJUZq4","pdf",1161774,13,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Retinoblastoma gene and knowledge gaps\n## Study aims\n# Methods\n## Patient samples and sequencing strategy","[{\"question\":\"What was the objective of the study regarding ophthalmic tumors?\",\"answer\":\"To clarify genomic events linked to poor outcomes in ophthalmic tumor patients, beyond the role of the retinoblastoma gene (RB1).\"},{\"question\":\"How were genes and mutations identified in the methods section?\",\"answer\":\"The study used combined exome sequencing and transcriptome sequencing to detect somatic point/small indel variants, copy-number variations, susceptibility genes, and driver genes in tumor and control samples.\"},{\"question\":\"Which signaling pathway and key genes were concluded to be involved in ophthalmic tumorigenesis?\",\"answer\":\"TP53 was highlighted as clearly involved, especially in basal cell carcinoma, and pathway enrichment suggested PI3K-Akt signaling as essential; RUNX1, SMO, TOP2A, and ZWINT were also implicated for further validation.\"}]","Integrative Genomic Analysis Reveals Cancer-Associated Mutations in Patients With Ophthalmic Tumors | PDF",1790021454,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fb3f302fb39e9084b6a05fcaead5b14e.webp",983,1399,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/be84eca67ec5890aaf32a2e10227daff.webp",982,1398,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cd246d8f47ca3a9d3271c9077d41646b.webp",981,1396,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e1101e753410b8871e41cdd8288bd828.webp",980,1395]